SecBot SecBot
8-K ·Filed May 4, 2026

OCGN

Ocugen, Inc.
MIXED
Impact 6/10
Horizondays Processed6mo ago SEC0001104659-26-054866
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

Monitor pricing terms (interest rate, conversion price) to gauge dilution impact and market reception. The offering extends cash runway but adds convertible debt that could be dilutive; watch for potential insider selling or further dilution if stock trades near conversion price.

DirectionMixed
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.49
T+0 close · May 4, 2026 · via day close
Latest settled
−15.44%
T+60 · $1.26
Vs SPY
−18.18%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $1.49entry
  2. T+1 · 7mo ago 0.00%α −1.38% · $1.49
  3. T+5 · 6mo ago −0.67%α −2.66% · $1.48
  4. T+20 · 6mo ago −10.07%α −15.02% · $1.34
  5. T+60 · 4mo ago −15.44%α −18.18% · $1.26
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Ocugen announced a private offering of $115M convertible senior notes due 2034 (plus $15M option), intending to use ~$32.7M to repay existing Avenue loan and the remainder for general corporate purposes. The filing also provides preliminary cash of $32.2M as of March 31, 2026. This capital raise extends runway but introduces dilution overhang.

Key Facts

  • Private offering of $115M aggregate principal amount of convertible senior notes due 2034
  • Initial purchaser granted 13-day option to purchase up to an additional $15M of notes
  • Approximately $32.7M of net proceeds to fully repay Avenue Loan Agreement
  • Preliminary cash, cash equivalents, and restricted cash of ~$32.2M as of March 31, 2026
  • 338,318,899 shares of common stock outstanding as of March 31, 2026

Financial Impact

$115M gross proceeds; net of ~$32.7M debt repayment and fees, net proceeds ~$80M+; prior cash $32.2M

dilutiondebtcash

Risk Factors

  • Potential dilution upon conversion of notes
  • Uncertainty in market conditions may alter offering terms
  • Conversion price and interest rate not yet determined
  • Pre-revenue biotech with ongoing cash burn

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-054866
Document: tm2613474d1_ex99-1.htm0001104659-26-054866
Document: tm2613474d1_ex99-2.htm0001104659-26-054866
Document: 0001104659-26-054866-index-headers.html0001104659-26-054866
Document: 0001104659-26-054866-index.html0001104659-26-054866
Document: 0001104659-26-054866.txt0001104659-26-054866
8-K Data (Synthetic)0001104659-26-054866

Track record

23 reports on OCGN

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +20.49% at T+20 after the Jun 11, 2026 report. 4 of 6 went positive at some point.

Filters
  1. Nov 10, 20266d ago 8-K Neutral 4/10 Entry $0.9500 to $0.9604 Now $0.7730 −18.63% ▲ +1.09% −0.22% vs SPY
  2. Nov 10, 20266d ago Press Release Neutral 4/10 Entry $0.9500 to $0.9604 Now $0.7730 −18.63% ▲ +1.09% −0.22% vs SPY
  3. Nov 6, 202610d ago DEFA14A Neutral 2/10 Entry $0.9721 to $0.9500 Now $0.7730 −20.48% ▼ −2.27% −1.91% vs SPY
  4. Nov 6, 202610d ago DEFA14A Neutral 3/10 Entry $0.9721 to $0.9500 Now $0.7730 −20.48% ▼ −2.27% −1.91% vs SPY
  5. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  6. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $0.8745 to $0.8165 Now $0.7730 −11.61% ▼ −6.63% −2.22% vs SPY
  7. Oct 15, 20264w ago 8-K Neutral 5/10 Entry $0.8137 to $0.7803 Now $0.7730 −5.00% ▼ −4.10% −3.00% vs SPY
  8. Oct 14, 20264w ago 8-K Mixed 5/10 Entry $0.8137 to $0.7803 Now $0.7730 −5.00% ▼ −4.10% −3.00% vs SPY
  9. Oct 9, 20265w ago 144 Neutral 2/10 Entry $0.9472 to $0.8854 Now $0.7730 −18.39% ▼ −6.52% −6.51% vs SPY
  10. Sep 1, 202610w ago Press Release Bullish 7/10 Entry $1.33 to $1.32 Now $0.7730 −41.88% ▼ −0.75% −1.20% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026